Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HSGX

Histogenics (HSGX) Stock Price, News & Analysis

Histogenics logo

About Histogenics Stock (NASDAQ:HSGX)

Advanced Chart

Key Stats

Today's Range
$1.11
$1.19
50-Day Range
$0.16
$3.07
52-Week Range
$0.08
$1.43
Volume
4.19 million shs
Average Volume
9.06 million shs
Market Capitalization
$107.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HSGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogenics and its competitors with MarketBeat's FREE daily newsletter.

HSGX Stock News Headlines

Traphaco JSC TRA
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.
See More Headlines

HSGX Stock Analysis - Frequently Asked Questions

Histogenics Corp (NASDAQ:HSGX) issued its earnings results on Thursday, August, 9th. The biotechnology company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.10.

Histogenics (HSGX) raised $60 million in an initial public offering (IPO) on Wednesday, December 3rd 2014. The company issued 4,300,000 shares at $13.00-$15.00 per share. Cowen and Company, Needham & Company and Canaccord Genuity acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogenics investors own include Interpace Biosciences (IDXG), Verastem (VSTM), Progenics Pharmaceuticals (PGNX), Novavax (NVAX), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and OPKO Health (OPK).

Company Calendar

Last Earnings
8/09/2018
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical Appliances & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:HSGX
CIK
1372299
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-34.96%
Return on Assets
18.40%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.05
Quick Ratio
4.05

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-114.00

Miscellaneous

Outstanding Shares
94,599,000
Free Float
N/A
Market Cap
$107.84 million
Optionable
Not Optionable
Beta
3.10
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:HSGX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners